Author

E. Gebhard-Hartmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

B. Polat· 1 shared C. Muench· 1 shared C. Prieto-Garcia· 1 shared C. Schuelein-Voelk· 1 shared K. Klann· 1 shared M. E. Diefenbacher· 1 shared M. Flentje· 1 shared M. Reissland· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Polat

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 24, 2021

PTEN mutant NSCLC require ATM to suppress pro-apoptotic signalling and evade radiotherapy

T. Fischer, O. Hartmann, M. Reissland…·M. E. Diefenbacher

This study shows PTEN-deficient NSCLC cells rely on ATM to repair radiation damage and resist therapy, and ATM inhibition synergizes with radiation in these models.

DOI 10.1101/2021.07.24.453632

humanmouse